Show simple item record

Efficacy and safety of nintedanib (NIN)/docetaxel (DOC) in patients with lung adenocarcinoma: further analyses from the LUME-Lung 1 study.

dc.contributor.authorHeigener, D
dc.contributor.authorGottfried, M
dc.contributor.authorBennouna, J
dc.contributor.authorBondarenko, I
dc.contributor.authorDouillard, J
dc.contributor.authorKrzakowski, M
dc.contributor.authorMellemgaard, A
dc.contributor.authorNovello, S
dc.contributor.authorOrlov, S
dc.contributor.authorSummers, Yvonne J
dc.contributor.authorvon Pawel, J
dc.contributor.authorHocke, J
dc.contributor.authorKaiser, R
dc.contributor.authorReck, M
dc.date.accessioned2017-05-02T19:50:06Z
dc.date.available2017-05-02T19:50:06Z
dc.date.issued2016-10-01
dc.identifier.citationEfficacy and safety of nintedanib (NIN)/docetaxel (DOC) in patients with lung adenocarcinoma: further analyses from the LUME-Lung 1 study. 2016, 27(suppl 6):1276P Annals of Oncologyen
dc.identifier.issn0923-7534
dc.identifier.issn1569-8041
dc.identifier.doi10.1093/annonc/mdw383.76
dc.identifier.urihttp://hdl.handle.net/10541/620309
dc.language.isoenen
dc.relation.urlhttps://academic.oup.com/annonc/article/2800170/Efficacyen
dc.rightsArchived with thanks to Annals of Oncologyen
dc.titleEfficacy and safety of nintedanib (NIN)/docetaxel (DOC) in patients with lung adenocarcinoma: further analyses from the LUME-Lung 1 study.en
dc.typeMeetings and Proceedingsen
dc.contributor.departmentDepartment of Thoracic Oncology, LungenClinic Grosshansdorf, Grosshansdorfen
dc.identifier.journalAnnals of Oncologyen


This item appears in the following Collection(s)

Show simple item record